Lineage Cell Therapeutics, Inc. reports

Company location: Carlsbad, CA
Fiscal year end: 31 December

Lineage Cell Therapeutics, Inc. has filed 1,802 SEC EDGAR filings since 17 Apr 1996

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 451-475 of 1,000 matching filings.

Per page

25

Current page

19

5

FORM 5 SUBMISSION

Filing date: 14 Feb 2018
Reporting date: 31 Dec 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

5

FORM 5 SUBMISSION

Filing date: 14 Feb 2018
Reporting date: 31 Dec 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 12 Jan 2018
Reporting date: 10 Jan 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 12 Jan 2018
Reporting date: 10 Jan 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

CT ORDER File 001-12830

CT ORDER filing

Filing date: 14 Dec 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-12830

8-K filing

Filing date: 11 Dec 2017
Reporting date: 05 Dec 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

SC 13D/A filing

Filing date: 15 Nov 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

SC 13D/A filing

Filing date: 15 Nov 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-12830

10-Q

Filing date: 09 Nov 2017
Reporting date: 30 Sep 2017
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-12830

BIOTIME, INC. 8-K

Filing date: 09 Nov 2017
Reporting date: 09 Nov 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

OWNERSHIP DOCUMENT

Filing date: 17 Oct 2017
Reporting date: 13 Oct 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-12830

8-K filing

Filing date: 16 Oct 2017
Reporting date: 10 Oct 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

424B5 File 333-217182

424B5 filing

Filing date: 13 Oct 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-12830

8-K filing

Filing date: 13 Oct 2017
Reporting date: 13 Oct 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 12 Oct 2017
Reporting date: 10 Oct 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 12 Oct 2017
Reporting date: 10 Oct 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

424B5 File 333-217182

424B5 filing

Filing date: 12 Oct 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-12830

BIOTIME, INC. 8-K

Filing date: 26 Sep 2017
Reporting date: 26 Sep 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

CT ORDER File 001-12830

CT ORDER filing

Filing date: 12 Sep 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-12830

8-K filing

Filing date: 11 Sep 2017
Reporting date: 07 Sep 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 25 Aug 2017
Reporting date: 23 Aug 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

OWNERSHIP DOCUMENT

Filing date: 24 Aug 2017
Reporting date: 22 Aug 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 23 Aug 2017
Reporting date: 22 Aug 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 23 Aug 2017
Reporting date: 21 Aug 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 22 Aug 2017
Reporting date: 21 Aug 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .